Pure Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,061
Closed -$212K 307
2023
Q3
$212K Buy
3,061
+357
+13% +$24.7K 0.01% 248
2023
Q2
$255K Sell
2,704
-15,111
-85% -$1.43M 0.01% 227
2023
Q1
$1.47M Buy
17,815
+100
+0.6% +$8.27K 0.07% 101
2022
Q4
$1.32M Sell
17,715
-28
-0.2% -$2.09K 0.07% 104
2022
Q3
$1.47M Buy
17,743
+20
+0.1% +$1.65K 0.09% 93
2022
Q2
$1.69M Buy
17,723
+1,889
+12% +$180K 0.1% 90
2022
Q1
$1.86M Sell
15,834
-18
-0.1% -$2.12K 0.09% 84
2021
Q4
$2.05M Sell
15,852
-23
-0.1% -$2.98K 0.1% 77
2021
Q3
$1.8M Buy
15,875
+59
+0.4% +$6.68K 0.14% 75
2021
Q2
$1.64M Sell
15,816
-510
-3% -$52.8K 0.13% 81
2021
Q1
$1.37M Sell
16,326
-30
-0.2% -$2.51K 0.14% 79
2020
Q4
$1.49M Buy
16,356
+30
+0.2% +$2.74K 0.18% 76
2020
Q3
$1.3M Hold
16,326
0.19% 69
2020
Q2
$1.13M Buy
16,326
+243
+2% +$16.8K 0.18% 67
2020
Q1
$1.01M Hold
16,083
0.17% 63
2019
Q4
$1.25M Hold
16,083
0.21% 61
2019
Q3
$1.18M Hold
16,083
0.21% 60
2019
Q2
$990K Buy
16,083
+267
+2% +$16.4K 0.18% 64
2019
Q1
$1.01M Sell
15,816
-300
-2% -$19.1K 0.19% 62
2018
Q4
$823K Buy
16,116
+666
+4% +$34K 0.17% 69
2018
Q3
$897K Buy
+15,450
New +$897K 0.2% 62
2017
Q4
Sell
-14,079
Closed -$513K 26
2017
Q3
$513K Hold
14,079
0.13% 69
2017
Q2
$555K Buy
14,079
+1,725
+14% +$68K 0.15% 66
2017
Q1
$387K Hold
12,354
0.11% 79
2016
Q4
$386K Hold
12,354
0.12% 73
2016
Q3
$496K Hold
12,354
0.16% 58
2016
Q2
$411K Buy
12,354
+1,869
+18% +$62.2K 0.14% 63
2016
Q1
$314K Buy
10,485
+339
+3% +$10.2K 0.11% 73
2015
Q4
$267K Hold
10,146
0.12% 57
2015
Q3
$240K Hold
10,146
0.11% 56
2015
Q2
$241K Buy
10,146
+1,170
+13% +$27.8K 0.12% 62
2015
Q1
$213K Buy
+8,976
New +$213K 0.07% 56